{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Chlordiazepoxide Hydrochloride and Clidinium Bromide is a prescription medication combining a benzodiazepine and an anticholinergic to help manage symptoms of irritable bowel syndrome, such as abdominal pain and spasms. It comes as oral capsules (5 mg chlordiazepoxide and 2.5 mg clidinium) and is a controlled substance (Schedule CIV). Manufactured by Alembic Pharmaceuticals Inc. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Chlordiazepoxide hydrochloride and clidinium bromide \u2014 ANDA 213530 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213530", "mediaType": "text/html", "title": "Chlordiazepoxide hydrochloride and clidinium bromide"}], "identifier": "ANDA213530", "issued": "2016-09-16", "keyword": ["drug-manufacturers", "drug-safety", "health-care", "prescription-drugs", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Chlordiazepoxide hydrochloride and clidinium bromide"}